3-methyl-5-nitro-7-methoxybenzofuran | 153001-65-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: 3-methyl-5-nitro-7-methoxybenzofuran
• 英文别名: 7-Methoxy-3-methyl-5-nitro-1-benzofuran
• CAS: 153001-65-1
• 化学式: C₁₀H₉NO₄
• 分子量: 207.186
• InChiKey: QEUSSSQSTGXQJP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  68.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-methyl-5-nitro-7-methoxybenzofuran 在 platinum(IV) oxide 氢气 、 吡啶盐酸盐 、 sodium hydride 作用下， 以 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 24.0~170.0 ℃ 、137.9 kPa 条件下， 反应 8.5h， 生成 7-Benzyloxy-3-methyl-benzofuran-5-ylamine
  参考文献：
  名称：

  Total synthesis and biological properties of novel antineoplastic (chloromethyl)furanoindolines: an asymmetric hydroboration mediated synthesis of the alkylation subunits

  摘要：

  1,2-Dihydro-1-(chloromethyl)-5-hydroxy-8-methyl-3H-furano[3,2-e] indole (CFI) as a novel re; placement of the cyclopropylpyrroloindoline (CPI) alkylation subunit of CC-1065, U-71184, and U-73975 (adozelesin) has been synthesized and incorporated into a series of efficacious antineopIastic agents. A partial solution to an asymmetric synthesis of the CFI alkylation subunit has been achieved by the implementation of an asymmetric hydroboration reaction of an intermediate 3-methyleneindoline (13). Extension to the asymmetric synthesis of the CBI and CI alkylation subunits is presented. The demonstration and comparative study of the sequence-selective DNA alkylation properties of the CFI-based agents are detailed, and the preliminary in vitro and in vivo antineoplastic propertes of these agents in the human epidermoid cell lung carcinoma (T222) are described.

  DOI：

  10.1021/jm00028a005
• 作为产物：
  描述：

  potassium 2-methoxy-4-nitrophenolate 在 PPA 、 二甲基硫 、 臭氧 、 potassium iodide 作用下， 以 水 、 丙酮 、 甲苯 、 苯 为溶剂， 反应 38.5h， 生成 3-methyl-5-nitro-7-methoxybenzofuran
  参考文献：
  名称：

  Total synthesis and biological properties of novel antineoplastic (chloromethyl)furanoindolines: an asymmetric hydroboration mediated synthesis of the alkylation subunits

  摘要：

  1,2-Dihydro-1-(chloromethyl)-5-hydroxy-8-methyl-3H-furano[3,2-e] indole (CFI) as a novel re; placement of the cyclopropylpyrroloindoline (CPI) alkylation subunit of CC-1065, U-71184, and U-73975 (adozelesin) has been synthesized and incorporated into a series of efficacious antineopIastic agents. A partial solution to an asymmetric synthesis of the CFI alkylation subunit has been achieved by the implementation of an asymmetric hydroboration reaction of an intermediate 3-methyleneindoline (13). Extension to the asymmetric synthesis of the CBI and CI alkylation subunits is presented. The demonstration and comparative study of the sequence-selective DNA alkylation properties of the CFI-based agents are detailed, and the preliminary in vitro and in vivo antineoplastic propertes of these agents in the human epidermoid cell lung carcinoma (T222) are described.

  DOI：

  10.1021/jm00028a005

文献信息

• Furanoindolines
  申请人：Eli Lilly and Company

  公开号：US05248691A1

  公开（公告）日：1993-09-28

  This invention provides novel furanoindoline compounds effective in inhibiting the growth of solid tumors.

  这项发明提供了一种新型的呋喃吲哚衍生物化合物，能够有效抑制实体肿瘤的生长。
• Furanoindoline derivatives and their use as antitumor agents
  申请人：ELI LILLY AND COMPANY

  公开号：EP0586254A1

  公开（公告）日：1994-03-09

  This invention provides novel furanoindoline compounds of formula I effective in inhibiting the growth of solid tumors.

  本发明提供了有效抑制实体瘤生长的新型式 I 呋喃吲哚啉化合物。
• US5248691A
  申请人：——

  公开号：US5248691A

  公开（公告）日：1993-09-28